NCT00280618View on ClinicalTrials.gov

Oxaliplatin in Unresectable Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2006

Conditions
Carcinoma, Hepatocellular
Interventions
DRUG

Oxaliplatin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00280618 - Oxaliplatin in Unresectable Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter